ArticleClinical ophthalmology (Auckland, N.Z.)2023
Early Clinical Experience with a New Hydrophobic Acrylic Single-Piece Monofocal Intraocular Lens.
Article in Clinical ophthalmology (Auckland, N.Z.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 9 citations in OpenAlex.
- Clinical Outcomes of a Monofocal, Optimized, Aspheric IOL in Eyes with Different Degrees of Corneal Spherical Aberration.Clinical ophthalmology (Auckland, N.Z.) · 2026Trial
- Capsular bag performance of an aspheric hydrophobic IOL after conventional phacoemulsification or femtosecond laser-assisted cataract surgery: 12-month results of a randomized prospective study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025Trial
- Article
- Evaluation of visual outcomes, optical quality, and patient satisfaction with a novel monofocal intraocular lens.BMC ophthalmology · 2026Article
- Short-Term Visual and Optical Performance of the ZEISS CT LUCIA 621P Intraocular Lens Across Different Power Ranges.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Review
- Preliminary findings from a retrospective comparative study on a novel hydrophobic C-loop monofocal intraocular lens.Scientific reports · 2025Article
- Visual and Refractive Outcomes of a New Monofocal, Non-Constant Aberration-Correcting Aspheric Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Preliminary Evaluation of Clinical and Non-Clinical Outcome Metrics in Patient Satisfaction After Implantation of a Non-Constant Aberration-Correcting Monofocal IOL.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Randomized controlled bilateral comparison of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification.BMJ surgery, interventions, & health technologies · 2025Article
- Visual Outcomes of a New Hydrophobic Trifocal Intraocular Lens in Cataract Treatment: A Prospective Clinical Study.Journal of ophthalmology · 2025Article
- Through-focus performance and off-axis effects in aspheric monofocal intraocular lenses.Biomedical optics express · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate early clinical outcomes and adverse events (AEs) in cataract patients following implantation of a monofocal hydrophobic acrylic IOL with a new optimized non-constant aberration-correcting design (CT LUCIA 621P). Methods: This retrospective study included patients with visually significant cataracts who underwent implantation of the CT LUCIA 621P IOL. Refraction, corrected (CDVA) and uncorrected (UDVA) visual acuity of the last available visit were used in the analysis. Intraoperative and postoperative AEs of the cohort were reviewed. Results: A total of 191 eyes of 133 patients with the mean age of 70.2±11.2 years were included in this study. The mean follow-up time of the last available visit was 1.7±1.3 months. The mean postoperative monocular UDVA was 0.09±0.16 logMAR (≈20/25), and 74.9% (143/191) eyes achieved ≥20/25 UDVA. The percentage of eyes with manifest spherical equivalent (MSE) within ±0.50D and ±1.00D of emmetropia was 84.8% (162/191) and 98.4% (188/191), respectively. Linear regression of attempted vs achieved MSE showed a tight relationship, with the coefficient of determination close to 1 (R Conclusion: The implantation of CT LUCIA 621P resulted in good refractive predictability and visual outcomes. No IOL-related adverse events were reported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.